Concepedia

Kirk M. Maxey

KM

6

Publications

151

Citations

6

H-Index

1980

Active since

Affiliations

Cayman Chemical (United States)(Current)

Kirk M. Maxey is an author at Cayman Chemical (United States) specializing in medicine, bioanalysis, and immunology.

Top concepts

MedicineBioanalysisImmunologyPharmacologyChromatographyUrologyChemistryNephrologyBiochemistryDrug Analysis

Publications per year

1980–2012

6

Publications

6

PG<scp>E<sub>2</sub></scp>maintains the tone of the guinea pig trachea through a balance between activation of contractile<scp>EP<sub>1</sub></scp>receptors and relaxant<scp>EP<sub>2</sub></scp>receptors

Jesper Säfholm, S‐E Dahlén, Ingrid Delin et al. · British Journal of Pharmacology · 2012 · 48 citations · Full text

A quantitative solid-phase enzymeimmunoassay for 13,14-dihydro-15-keto-prostaglandin F2α in plasma

R.P. Del Vecchio, Kirk M. Maxey, Gregory S. Lewis · Prostaglandins · 1992 · 27 citations

Quantitative Solid-phase Enzymeimmunoassay, Biochemistry, Bioanalysis +4

Immunoaffinity Resin for Purification of Urinary Leukotriene E4

Jay Y. Westcott, Kirk M. Maxey, J. C. MacDonald et al. · Prostaglandins & Other Lipid Mediators · 1998 · 27 citations

Bioanalysis, Immunology, Immunochemistry +6

The synthesis of 11a-carbathromboxane A2

Kirk M. Maxey, Gordon L. Bundy · Tetrahedron Letters · 1980 · 19 citations

Organic Chemistry, Synthetic Chemistry, 11A-carbathromboxane A2 +1

Synthesis of 15R-PGD2: a potential DP2 receptor agonist

Seong Jin Kim, Sophie Bellone, Kirk M. Maxey et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 16 citations · Full text

Molecular Pharmacology, G Protein-coupled Receptor, Medicine +3

Rows per page

1–5 of 6